Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples

Recruiting N/A Interventional Study
Periodontitis Trisomy 21
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 – 12
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
18 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Since 2018, the Chicago Classification of Periodontal Diseases and Conditions, has listed Down syndrome (DS)/trisomy 21 (T21) as a systemic disease with periodontal implications. Numerous studies report an increased prevalence and severity of periodontitis in DS/T21 individuals under the age of 35. Approximately 35% of adolescents with DS show early signs of alveolar bone loss. However, very few s…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Common to all groups: * Age: 3 to 12 * Patient affiliated to a social security program, beneficiary not covered by the AME. * Legal representatives who speak and understand French well enough to be able to read and understand the study information. * Legal representatives givin…
Contacts

Marjolaine Ms GOSSET, PU-PH

0149594811

marjolaine.gosset@aphp.fr; marjolaine.gosset@u-paris.fr

CONTACT

Anne Laure Ms BONNET, MCU-PH

0149594811

anne-laure.bonnet@aphp.fr

CONTACT